2. PVC/VPC/PVB/Ventricle
Extrasystole
Premature impulse originating from ventricles
that occurs earlier than next expected normal
sinus rhythm.
Not preceded by P wave
QRS wide ≥ 0.12 sec
Followed by pause usually fully compensatory
5. Origin of PVC
Right ventricle Left ventricle
Morphology of V1
LBBB RBBB
Apex Out Flow In Flow
Inferoposterior
anterosuperior
LAD
RAD
Normal
LAD
RAD
6. Classification of ventricular
arrhythmia
Clinical – hemodynamic stable
- hemodynamic unstable
Electrocardiographical
Non sustained VT- Monomorphic or Polymorphic
Sustain VT- Monomorphic or Polymorphic
Bundle branch reentrant tachycardia
Bidirectional VT
Torsades de points
Ventricular flutter
Ventricular fibrillation
7. Ventricular tachycardia
3 or more consecutive PVC with rate > 100/ min
Non sustain if lasting < 30 sec
Sustain if lasting > 30 sec or
< 30 sec but associated with hemodynamic
compromise
8. Bundle branch reentrant
tachycardia
VT is due to Reentry
Rt ventricle Septum Lt ventricle
During NSR baseline ECG shows incomplete
or complete LBBB
May respond to radiofrequency ablation
9. Bidirectional tachycardia
VT originates from two separate locations
1. Left anterior fascicles & 2. left posterior fascicles
RBBB + Right Axis RBBB + Left Axis
Axis alternate between right and left axis in frontal
plane
Frequently associated with digitalis toxicity
10. Torsades de Pointes
Polymorphic VT associated with prolonged QTc interval
QTc prolonged if > 0.44 sec in men
> 0.46 sec in women and
children
Pause dependent occurring when there is bradycardia.
Frequently seen in setting of long and short cycles
11. Ventricular Flutter
Similar to monomorphic VT with rate > 250/min
No isoelectric interval between QRS complex.
Ventricular Fibrillation
Disorganised ventricular rhythm with poorly
defined QRS.
Rate > 300/min
12. Wide Complex Tachycardia
VT
SVT with
○ Preexistent BBB
○ Antidromic AVRT
○ Ventricular Aberration or rate related BBB
13. VT v/s SVT
If single rhythm strip available
Unusally wide QRS
Complete AV dissociation.
15. Sinus captured complex or Dressler complex
Ventriculoatrial conduction with block.
16. In 12 lead ECG
Brugada Algorithm
Vereckei algorithm
aVR Vereckei Algorithm
Lead II R wave peak time RWPT
17.
18. Brugada Algorithm
Absence of an RS complex
in all precordial leads?
R to S interval > 100ms in
one precordial lead ?
Morphology criteria for VT
present in precordial leads
V1-2 and V6 ?
A V dissociation ?
SVT
VT
VT
VT
VT
No
No
No
No
Yes
Yes
Yes
Yes
19.
20.
21.
22.
23. 4 a. LBBB morphology: Dominant S wave in V1 or V2
Lead V1 or V2
R Wave duration ≥ 0.04 sec
RS duration ≥ 0.07 sec
Slurring or notching of S wave (Josephson Sign)
Lead V 6
Any q wave
24. 4 b. RBBB morphology: Dominant R wave in V1 or V2
Lead V1
Monophasic R wave
Biphasic QRS complex ( qR ,Rs)
Lead V 6
Any QS complex
R/S ratio < 1 means R smaller than S
25.
26. Vereckei Algorithm
AV dissociation present ?
Initial R wave in aVR
Present ?
Vi/Vt ≤ 1 ?
QRS morphology unlike BBB
of FB ?
SVT
VT
VT
VT
VT
No
No
No
No
Yes
Yes
Yes
Yes
27. aVR criteria
1. Presence of initial R wave in aVR.
2. Presence of initial r or q wave of > 0.40 sec
3. Nothching of initial downstroke of a
predominantly negative QRS
If any of three present its VT, when absent 4th
criteria is analysed
4. Ventricular activation velocity ratio Vi/Vt ≤ 1
29. Lead II R Wave Peak Time
Criteria
Time of intrinsicoid deflection measured
in lead II i.e onset of peak of first
positive or negative deflection.
30. Other findings for d/g of VT
1. RBBB morphology with LAD> -30
2. LBBB morphology with RAD > +90
3. Northwest Axis
4. Concordance QRS complex
5. Rabbit ear
32. Treatment of Ventricular Fibrillation
DC Cardioversion
Precordial thump
CPR
Pharmacologic agents
Epinephrine 1mg stat repeated 3-5 min
Amiodarone 300 mg stat 1.0mg/min for 6 hr
Follwed by 0.5mg/min for next 18 hr.
33. Treatment of Sustain Monomorphic VT
Unstable patient: synchronised cardioversion.
Stable patient with EF > 40%
Procainamide 17mg /kg loading f/b maintenance 1-
4mg/min
Amiodarone 150mg bolus f/b infusion 1mg/min for 6 hr
0.05mg/min for 18 hr
Lidocaine 1mg/kg bolus f/b maintenance 1-4 mg/min
Treatment of Sustain Polymorphic VT
Mostly unstable DC Cardioversion f/b pharmacotherapy
depending on Qtc interval
Regular PVT- usually a/w myocardial ischemia, AAD similar to
monomorphic VT